Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Receives Consensus Rating of "Hold" from Analysts

DocuSign logo with Computer and Technology background

DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) has been given a consensus recommendation of "Hold" by the thirteen brokerages that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $92.45.

A number of equities analysts have recently commented on the stock. Wells Fargo & Company raised their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research report on Friday, December 6th. Needham & Company LLC restated a "hold" rating on shares of DocuSign in a research report on Friday, December 6th. Citigroup increased their price objective on DocuSign from $87.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, December 6th. HSBC restated a "reduce" rating on shares of DocuSign in a research report on Friday, December 6th. Finally, Morgan Stanley raised their price target on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a report on Friday, December 6th.

Check Out Our Latest Analysis on DocuSign

DocuSign Trading Down 0.2 %

Shares of DOCU stock opened at $96.50 on Tuesday. DocuSign has a 12 month low of $48.70 and a 12 month high of $107.86. The stock has a market capitalization of $19.50 billion, a P/E ratio of 19.90, a PEG ratio of 8.74 and a beta of 0.88. The firm's 50 day moving average is $91.32 and its 200 day moving average is $73.08.

Insider Activity at DocuSign

In other news, CEO Allan C. Thygesen sold 7,763 shares of the company's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the transaction, the chief executive officer now directly owns 100,062 shares of the company's stock, valued at approximately $8,058,993.48. This represents a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the transaction, the director now directly owns 7,736 shares in the company, valued at $731,825.60. This represents a 6.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 685,773 shares of company stock worth $66,032,726. Company insiders own 1.66% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. State Street Corp lifted its stake in DocuSign by 2.3% in the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company's stock valued at $333,604,000 after buying an additional 120,743 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of DocuSign by 1.6% during the third quarter. Geode Capital Management LLC now owns 3,483,184 shares of the company's stock valued at $215,789,000 after acquiring an additional 53,554 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of DocuSign by 5.2% in the third quarter. Thrivent Financial for Lutherans now owns 2,277,312 shares of the company's stock worth $141,398,000 after acquiring an additional 112,919 shares during the last quarter. FMR LLC increased its position in shares of DocuSign by 16.8% during the third quarter. FMR LLC now owns 2,192,885 shares of the company's stock worth $136,156,000 after purchasing an additional 315,073 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in DocuSign by 14.4% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,659,367 shares of the company's stock valued at $103,030,000 after purchasing an additional 208,813 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

About DocuSign

(Get Free Report

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines